Current Report Filing (8-k)

Date : 06/11/2019 @ 10:15PM
Source : Edgar (US Regulatory)
Stock : Medicinova, Inc. (MNOV)
Quote : 9.71  0.07 (0.73%) @ 12:59AM

Current Report Filing (8-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 10, 2019

 

 

MEDICINOVA, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

 

 

 

DELAWARE

 

001-33185

 

33-0927979

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

 

4275 EXECUTIVE SQUARE,

SUITE 300, LA JOLLA, CA

 

92037

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (858) 373-1500

Not applicable.

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: 

 

Common Stock, $0.001 par value

 

MNOV

 

The Nasdaq Stock Market LLC

(Title of each class)

 

(Trading symbol(s))

 

(Name of each exchange on which registered)

 

 


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company              

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.        

 

 

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

MediciNova, Inc . (the “Company”) held its 2019 annual meeting of stockholders on June 10, 2019 (the “Annual Meeting”). The Company filed its definitive proxy statement for the proposals voted upon at the Annual Meeting with the Securities and Exchange Commission on April 26, 2019 (the “Proxy Statement”).

At the close of business on April 11, 2019, the record date of the Annual Meeting, the Company had 43,061,161 shares of common stock issued and outstanding. The holders of a total of 30,681,971 shares of common stock were present at the Annual Meeting, either in person or by proxy, which total constituted a quorum of the issued and outstanding shares on the record date of the Annual Meeting.

Set forth below are the results of the matters submitted for a vote of stockholders at the Annual Meeting

 

 

(1)

To elect two Class III Director nominees named below to serve until the 2022 Annual Meeting of stockholders and until their successors have been duly elected and qualified, or, if sooner, until their earlier death, resignation or removal. The named nominees were so elected, with the votes thereon at the Annual Meeting as follows:

Final Voting Results

 

 

 

 

 

 

 

Nominees

 

For

 

Against

Abstain

 

Broker Non-Vote

Yutaka Kobayashi

 

27,353,206

 

1,307,941

586,812

 

1,434,012

Yoshio Ishizaka

 

28,207,585

 

453,547

586,827

 

1,434,012

 

 

(2)

To ratify the selection of BDO USA, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2019. This proposal was approved, with the votes thereon at the Annual Meeting as follows:

Final Voting Results

 

 

 

 

 

 

 

For

 

Against

 

Abstain

 

Broker Non-Vote

29,602,492

 

383,393

 

694,086

 

2,000

 

 

 

(3)

To approve an amendment to the 2013 Equity Incentive Plan to increase the number of shares of Common Stock issuable under the Plan by 2,000,000 shares. This proposal was approved, with the votes thereon at the Annual Meeting as follows:

Final Voting Results

 

 

 

 

 

 

For

 

Against

 

Abstain

 

Broker Non-Vote

26,570,560

 

1,884,419

 

790,780

 

1,436,212

 

 

 

(4)

To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement. This proposal was approved, with the votes thereon at the Annual Meeting as follows:

Final Voting Results

 

 

 

 

 

 

For

 

Against

 

Abstain

 

Broker Non-Vote

27,806,693

 

653,518

 

784,048

 

1,437,712

 

 

(5)

To approve on, an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers of every one, two or three years. The preferred frequency of every 3 Years was approved, with the votes thereon at the Annual Meeting as follows:

Final Voting Results

 

 

 

 

 

 

 

 

 

Every 1 Year

 

Every 2 Years

 

Every 3 Years

 

 

Abstain

 

Broker Non-Vote

5,621,696

 

1,745,313

 

19,305,743

 

 

2,565,907

 

1,443,312

 

 

 

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

MEDICINOVA, INC.

 

 

 

 

 

By:

 

/s/ Carla Reyes

 

 

 

 

Carla Reyes

Chief Financial Officer

Date: June 11, 2019

 

 

 

 

 

 

Medicinova, Inc. (NASDAQ:MNOV)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more Medicinova, Inc. Charts.

Medicinova, Inc. (NASDAQ:MNOV)
Intraday Stock Chart

Today : Saturday 20 July 2019

Click Here for more Medicinova, Inc. Charts.

Latest MNOV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.